Market Trends Akero rises on planned release of mid-stage data on liver disease assetBy admin8996erT0allJanuary 24, 2025 Rasi Bhadramani Akero Therapeutics (NASDAQ:AKRO) is up ~5% in after-hours trading Friday after announcing it will hold a conference call…
Market Trends Surmodics drops after report on FTC’s view on planned sale to GTCR (SRDX:NASDAQ)By admin8996erT0allJanuary 13, 2025 hapabapaMedical device maker Surmodics (NASDAQ:SRDX) fell 6% after a report about the antitrust regulator’s possible view of its planned sale…
